Your browser doesn't support javascript.
loading
Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
Vermeulen, Roel; Saberi Hosnijeh, Fatemeh; Bodinier, Barbara; Portengen, Lützen; Liquet, Benoît; Garrido-Manriquez, Javiera; Lokhorst, Henk; Bergdahl, Ingvar A; Kyrtopoulos, Soterios A; Johansson, Ann-Sofie; Georgiadis, Panagiotis; Melin, Beatrice; Palli, Domenico; Krogh, Vittorio; Panico, Salvatore; Sacerdote, Carlotta; Tumino, Rosario; Vineis, Paolo; Castagné, Raphaële; Chadeau-Hyam, Marc; Botsivali, Maria; Chatziioannou, Aristotelis; Valavanis, Ioannis; Kleinjans, Jos C S; de Kok, Theo M C M; Keun, Hector C; Athersuch, Toby J; Kelly, Rachel; Lenner, Per; Hallmans, Goran; Stephanou, Euripides G; Myridakis, Antonis; Kogevinas, Manolis; Fazzo, Lucia; De Santis, Marco; Comba, Pietro; Bendinelli, Benedetta; Kiviranta, Hannu; Rantakokko, Panu; Airaksinen, Riikka; Ruokojarvi, Paivi; Gilthorpe, Mark; Fleming, Sarah; Fleming, Thomas; Tu, Yu-Kang; Lundh, Thomas; Chien, Kuo-Liong; Chen, Wei J; Lee, Wen-Chung; Kate Hsiao, Chuhsing.
Afiliação
  • Vermeulen R; Division of Environmental Epidemiology, Utrecht University, Institute for Risk Assessment Sciences, Utrecht, The Netherlands.
  • Saberi Hosnijeh F; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Bodinier B; Division of Environmental Epidemiology, Utrecht University, Institute for Risk Assessment Sciences, Utrecht, The Netherlands.
  • Portengen L; Immunology Department, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Liquet B; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Garrido-Manriquez J; Division of Environmental Epidemiology, Utrecht University, Institute for Risk Assessment Sciences, Utrecht, The Netherlands.
  • Lokhorst H; Laboratoire de Mathématiques et de leurs Applications, Université de Pau et des Pays de l'Adour, UMR CNRS, Pau, France.
  • Bergdahl IA; ARC Centre of Excellence for Mathematical and Statistical Frontiers, Queensland University of Technology (QUT), Brisbane, Australia.
  • Kyrtopoulos SA; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Johansson AS; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Georgiadis P; Department of Public Health and Clinical Medicine, and Department of Biobank Research, Umeå University, Umeå, Sweden.
  • Melin B; National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece.
  • Palli D; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Krogh V; National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece.
  • Panico S; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Sacerdote C; The Institute for Cancer Research and Prevention, Florence, Italy.
  • Tumino R; Fondazione IRCCS-Instituto Nazionale dei Tumori, Milan, Italy.
  • Vineis P; Department of Clinical Medicine and Surgery, University of Naples Frederico II, Naples, Italy.
  • Castagné R; Piedmont Reference Centre for Epidemiology and Cancer Prevention (CPO Piemonte), Turin, Italy.
  • Chadeau-Hyam M; Cancer registry and Histopathology Unit, Azienda Ospedaliera 'Civile-M.P.Arezzo', Ragusa, Italy.
  • Botsivali M; HuGeF Foundation, Torino, Italy.
  • Chatziioannou A; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Valavanis I; INSERM, UMR1027, Université Toulouse III-Paul Sabatier, Toulouse, France.
  • Kleinjans JCS; Division of Environmental Epidemiology, Utrecht University, Institute for Risk Assessment Sciences, Utrecht, The Netherlands.
  • de Kok TMCM; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Athersuch TJ; Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.
  • Kelly R; Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.
  • Lenner P; Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens, Greece.
  • Hallmans G; Department of Toxicogenomics, Maastricht University, Maastricht, The Netherlands.
  • Stephanou EG; Department of Toxicogenomics, Maastricht University, Maastricht, The Netherlands.
  • Myridakis A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Institute of Reproductive and Developmental Biology (IRDB), Hammersmith Hospital, London, United Kingdom.
  • Kogevinas M; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Fazzo L; Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • De Santis M; Immunology Department, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Comba P; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
  • Bendinelli B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Kiviranta H; Nutrition Research, Department of Public Health and Clinical Medicine, and Department of Biobank Research, Umeå University, Umeå, Sweden.
  • Rantakokko P; Environmental Chemical Processes Laboratory, University of Crete, Heraklion, Greece.
  • Airaksinen R; Environmental Chemical Processes Laboratory, University of Crete, Heraklion, Greece.
  • Ruokojarvi P; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Gilthorpe M; Istituto Superiore di Sanita, Rome, Italy.
  • Fleming S; Istituto Superiore di Sanita, Rome, Italy.
  • Fleming T; Istituto Superiore di Sanita, Rome, Italy.
  • Tu YK; The Institute for Cancer Research and Prevention, Florence, Italy.
  • Lundh T; National Institute for Health and Welfare, Kuopio, Finland.
  • Chien KL; National Institute for Health and Welfare, Kuopio, Finland.
  • Chen WJ; National Institute for Health and Welfare, Kuopio, Finland.
  • Lee WC; National Institute for Health and Welfare, Kuopio, Finland.
  • Kate Hsiao C; University of Leeds, Leeds, United Kingdom.
Int J Cancer ; 143(6): 1335-1347, 2018 09 15.
Article em En | MEDLINE | ID: mdl-29667176
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Linfoma Difuso de Grandes Células B / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Linfoma Difuso de Grandes Células B / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article